SCHEMBL6636282

SCHEMBL6636282

N#Cc1ccc(CSc2nc3ccc([N+](=O)[O-])cc3s2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.68
ALDH1A1 P00352 8/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
PDK1 Q15118 1/20 0.60
HTT P42858 5/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
CYP2C9 P11712 1/20 0.53
CYP3A4 P08684 2/20 0.49
TSHR P16473 2/20 0.49
CYP1A2 P05177 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
LMNA P02545 5/20 0.48
MAPK1 P28482 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
CA2 P00918 2/20 0.44
CA5A P35218 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635501 0.83 MAPT (0.67) MAPTALDH1A1MEN1KMT2AHTT
SCHEMBL9353715 0.78 RAB9A (0.61) MAPTALDH1A1KMT2AHTTSMN1; SMN2
SCHEMBL9353879 0.77 MAPT (0.71) MAPTALDH1A1MEN1KMT2AHTT
SCHEMBL10667967 0.76 PDK1 (1.00) MAPTALDH1A1MEN1KMT2APDK1
SCHEMBL2033524 0.75 PDK1 (0.53) MAPTALDH1A1MEN1KMT2APDK1
SCHEMBL27636935 0.74 MAPT (0.77) MAPTALDH1A1MEN1KMT2APDK1
SCHEMBL9389906 0.74 PDK1 (0.70) MAPTALDH1A1MEN1KMT2APDK1
SCHEMBL2380065 0.73 SMN1; SMN2 (0.61) MAPTALDH1A1MEN1KMT2APDK1
SCHEMBL10667970 0.73 PDK1 (0.78) MAPTALDH1A1MEN1KMT2APDK1
SCHEMBL76961 0.73 PDK1 (0.78) MAPTALDH1A1MEN1KMT2APDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed